Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$435M |
| 2 |
Amazon
AMZN
|
+$334M |
| 3 |
Moderna
MRNA
|
+$53.9M |
| 4 |
Linde
LIN
|
+$44.2M |
| 5 |
DTE Energy
DTE
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$63.6M |
| 2 |
Comcast
CMCSA
|
+$39.7M |
| 3 |
Evergy
EVRG
|
+$38.5M |
| 4 |
Public Service Enterprise Group
PEG
|
+$38.4M |
| 5 |
Bio-Techne
TECH
|
+$30.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 7.14% |
| 4 | Industrials | 6.8% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Chevron
CVX
$403B
| $6.71M | 0.07% |
+64,051
| New | +$6.76M |
|
|
ONC
252
BeOne Medicines Ltd
ONC
$42.4B
| $6.67M | 0.07% |
+19,442
| New | +$6.44M |
|
|
X
253
DELISTED
US Steel
X
| $6.59M | 0.07% |
+274,724
| New | +$6.76M |
|
254
Ally Financial
ALLY
$13.1B
| $6.59M | 0.07% |
132,233
+49,132
| +59% | +$2.52M |
|
255
BILL Holdings
BILL
$4.76B
| $6.55M | 0.07% |
35,751
+9,521
| +36% | +$1.49M |
|
256
Ross Stores
ROST
$76.7B
| $6.55M | 0.07% |
52,807
+30,066
| +132% | +$3.75M |
|
257
Liberty Energy
LBRT
$3.16B
| $6.51M | 0.07% |
+459,542
| New | +$6.2M |
|
258
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $6.5M | 0.07% |
73,822
-7,111
| -9% | -$621K |
|
|
LBRDK
259
DELISTED
Liberty Broadband Class C
LBRDK
| $6.49M | 0.07% |
37,384
+11,954
| +47% | +$1.92M |
|
|
SPWR
260
DELISTED
SunPower Corporation Common Stock
SPWR
| $6.48M | 0.07% |
221,755
+190,340
| +606% | +$4.91M |
|
261
PUT
Factset
FDS
$10.7B
| $6.45M | 0.07% |
+19,200
| New | +$6.29M |
|
262
PBF Energy
PBF
$8.72B
| $6.44M | 0.07% |
420,992
+364,541
| +646% | +$5.63M |
|
263
DHT Holdings
DHT
$3.2B
| $6.43M | 0.07% |
990,783
+31,682
| +3% | +$194K |
|
264
PUT
iShares MSCI EAFE ETF
EFA
$80B
| $6.41M | 0.07% |
81,200
+61,900
| +321% | +$4.92M |
|
265
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $6.37M | 0.07% |
115,521
-176,139
| -60% | -$9.57M |
|
266
Micron Technology
MU
$1.09T
| $6.36M | 0.07% |
74,777
-87,046
| -54% | -$7.35M |
|
267
Skyworks Solutions
SWKS
$10.1B
| $6.3M | 0.07% |
+32,832
| New | +$5.83M |
|
268
Kohl's
KSS
$2B
| $6.29M | 0.07% |
114,134
+79,121
| +226% | +$4.55M |
|
269
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $6.28M | 0.07% |
85,000
-344,086
| -80% | -$24.1M |
|
270
CALL
Warner Bros
WBD
$71.6B
| $6.26M | 0.07% |
+204,300
| New | +$7.09M |
|
271
Cerence
CRNC
$365M
| $6.25M | 0.07% |
58,537
+52,476
| +866% | +$5.16M |
|
272
McKesson
MCK
$100B
| $6.24M | 0.07% |
+32,630
| New | +$6.3M |
|
273
Verizon
VZ
$205B
| $6.24M | 0.07% |
111,361
+76,422
| +219% | +$4.39M |
|
274
Lowe's Companies
LOW
$121B
| $6.22M | 0.07% |
+32,077
| New | +$6.28M |
|
275
W.W. Grainger
GWW
$61.8B
| $6.2M | 0.07% |
14,159
-1,828
| -11% | -$807K |
|
Similar funds
Michael Gelband's Q2 2021 Portfolio in Review
As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.
- Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
- Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
- Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
- Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
- Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
- Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
- Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.